Innate Pharma SA (IPHYF) SEC Filings — 2024

Filings

• Innate Pharma Files 6-K Report — 6-K · Dec 20, 2024
• Innate Pharma Files 6-K Report — 6-K · Dec 9, 2024
• Innate Pharma Files 6-K Report — 6-K · Dec 6, 2024
• Innate Pharma Files 6-K Report — 6-K · Dec 3, 2024
• Innate Pharma Files 6-K, Issues Press Release — 6-K · Nov 20, 2024
• Innate Pharma Files 6-K Report — 6-K · Nov 19, 2024
• Innate Pharma Files 6-K Report — 6-K · Nov 13, 2024
• Innate Pharma Files 6-K Report — 6-K · Nov 8, 2024
• Innate Pharma Files 6-K Report — 6-K · Nov 7, 2024
• Innate Pharma Files 6-K, Names New CEO — 6-K · Oct 29, 2024
• Innate Pharma Files 6-K, Appoints New CEO — 6-K · Oct 15, 2024
• Innate Pharma Files 6-K Report — 6-K · Sep 30, 2024
• Innate Pharma Files 6-K Report — 6-K · Sep 23, 2024
• Innate Pharma SA Files 6-K for Q2 2024 — 6-K · Sep 12, 2024
• Innate Pharma SA Files 6-K Report — 6-K · Sep 12, 2024
• Innate Pharma Files Routine 6-K Report — 6-K · Sep 9, 2024
• Innate Pharma SA Files 6-K Report — 6-K · Sep 5, 2024
• Innate Pharma Files Routine 6-K with SEC — 6-K · Sep 4, 2024
• Innate Pharma Files Routine 6-K with SEC — 6-K · Jul 25, 2024
• Innate Pharma Files 6-K Report — 6-K · Jun 18, 2024
• Innate Pharma Files 6-K Report — 6-K · Jun 17, 2024
• Innate Pharma Files Routine 6-K Disclosure — 6-K · Jun 4, 2024
• Innate Pharma SA Files 6-K Report — 6-K · May 28, 2024
• Innate Pharma SA Files Form 6-K — 6-K · May 24, 2024
• Innate Pharma SA Files 6-K Report — 6-K · May 23, 2024
• Innate Pharma Files 6-K, Confirms 20-F Reporting — 6-K · May 15, 2024
• Innate Pharma SA Files Routine 6-K Disclosure — 6-K · May 14, 2024
• Innate Pharma SA Files Form 6-K — 6-K · May 7, 2024
• Innate Pharma Files 6-K, Submits Form 20-F — 6-K · Apr 15, 2024
• Innate Pharma SA Files 6-K Report — 6-K · Apr 10, 2024
• Innate Pharma SA Files 20-F Report for Fiscal Year Ended December 31, 2023 — 20-F · Apr 4, 2024
• Innate Pharma SA Files 6-K Report — 6-K · Mar 21, 2024
• Innate Pharma SA Files 6-K Report — 6-K · Mar 19, 2024
• Innate Pharma SA Files 6-K Report — 6-K · Mar 14, 2024
• Innate Pharma SA Files 6-K — 6-K · Mar 6, 2024
• Innate Pharma Files Routine 6-K, Confirms 20-F Reporting — 6-K · Feb 21, 2024
• Innate Pharma Confirms $75M 'At-The-Market' Equity Offering Program — 6-K · Feb 6, 2024
• Innate Pharma Reports 85.27M Shares & Voting Rights as of Jan 1, 2024 — 6-K · Jan 12, 2024
• FDA Lifts Partial Clinical Hold on Innate Pharma's Lacutamab IND — 6-K · Jan 5, 2024
• Innate Pharma Strengthens Leadership with Two New Executive Board Members — 6-K · Jan 4, 2024